Cargando…
SARS-CoV-2 Infection in Transplant-Related Biology: Where Do We stand?
Since December 2019, the novel coronavirus (SARS-CoV-2) emerged in Wuhan and rapidly spread throughout the world. There are nearly 3 951 905 confirmed cases of novel coronary pneumonia and more than 275 067 deaths worldwide, [JHU data-09/05/2020, https://www.arcgis.com/apps/opsdashboard/index.html#/...
Autores principales: | Kong, Deqiang, Li, Mingming, Gong, Weihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777149/ https://www.ncbi.nlm.nih.gov/pubmed/33372171 http://dx.doi.org/10.12659/AOT.924768 |
Ejemplares similares
-
SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?
por: Chakraborty, Saborni, et al.
Publicado: (2021) -
Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?
por: Joshi, Gaurav, et al.
Publicado: (2021) -
Vaccination against SARS-CoV-2 in Patients with Inflammatory Bowel Diseases: Where Do We Stand?
por: Tepasse, Phil-Robin, et al.
Publicado: (2021) -
Where Do We Stand?
Publicado: (1891) -
Liver transplantation for hepatocellular carcinoma: Where do we stand?
por: Santopaolo, Francesco, et al.
Publicado: (2019)